Skip to content

Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty

Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05017701
Enrollment
5
Registered
2021-08-24
Start date
2022-04-26
Completion date
2023-05-24
Last updated
2025-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

The aim of this research study is to gather data regarding the feasibility of the Bridge system for the management of pain following total hip arthroplasty (THA).

Interventions

Bridge is a percutaneous nerve field stimulation device which uses alternating currents of stimulation over a large field and with higher voltage in order to influence central pain areas.

DEVICESham device

The sham device has the same appearance and will require the same placement technique as the Bridge (active) device but will not deliver electrical impulses.

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is 18 years of age or older * Subject scheduled for elective primary unilateral total hip arthroplasty (THA) * Subject opioid use is less than 60 milligram morphine equivalent for the last 30 days * Subject has given written informed consent to participate in the study

Exclusion criteria

* Subjects who are pregnant or breastfeeding * Subjects with cardiac pacemakers or other implanted devices (e.g. vagal nerve simulators), hemophilia or psoriasis vulgaris * Subjects with a history of active depression, anxiety or catastrophizing * Subjects with active alcoholism or drug abuse * Subjects with severe chronic pain condition that requires daily preoperative opioid dependence * Subjects deemed not suitable for the study at the discretion of the principal investigator * Subjects who are concurrently participating in any other research study

Design outcomes

Primary

MeasureTime frameDescription
Change in Total Opioid Consumption Between Active and Sham Arms.Day of surgery to Day 5 (120 hours) post-opThe sample size is well below the threshold needed to reliably assess outcomes and perform statistical comparisons. As a result, we have provided the raw data for comparison of opioid consumption between the two groups.

Secondary

MeasureTime frameDescription
Change in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day of surgery to Day 5 (120 hours) post-opPain scores using a numerical scale will be collected at rest and movement and will be obtained prior to surgery, in the recovery room, prior to leaving the recovery room, every 6 hours during the first 24 hrs, and at 48, 72, 96 and 120 hours post-operatively. Subjects will use a 0-10 numeric scale (0 indicating no pain and 10 indicating extreme pain).
Change in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day of surgery to Day 5 (120 hours) post-opPostoperative nausea and vomiting will be evaluated from immediately after surgery through postoperative day 5, using a 0-10 scale (0 indicating no nausea and 10 indicating extreme nausea).
Change in Functional Recovery Between Active and Sham Arms Assessed Using the Timed Up and Go (TUG) Assessment Collected on Post-Op Day 30Day of surgery to post-operative day 30.Functional recovery will be assessed daily from day of surgery to post-op day 5, using the Timed Up and Go assessment to assess mobility.
Change in Functional Recovery Between Active and Sham Arms Assessed Using the 12-Item Short Form Survey (SF-12) Collected on Post-Op Day 30Day of surgery to post-operative day 30.Subjects will also complete the 12-Item Short Form Survey (SF-12) on Post-Op day 30 to evaluate quality of recovery.

Countries

United States

Participant flow

Participants by arm

ArmCount
Bridge Device
The active Bridge device delivers electrical stimulation to the cranial and occipital nerves. Bridge device: Bridge is a percutaneous nerve field stimulation device which uses alternating currents of stimulation over a large field and with higher voltage in order to influence central pain areas.
2
Sham Device
The sham device has the same appearance and will require the same placement technique as the Bridge (active) device but will not deliver electrical impulses Sham device: The sham device has the same appearance and will require the same placement technique as the Bridge (active) device but will not deliver electrical impulses.
3
Total5

Baseline characteristics

CharacteristicBridge DeviceSham DeviceTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants1 Participants3 Participants
Age, Categorical
Between 18 and 65 years
0 Participants2 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants0 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
1 Participants3 Participants4 Participants
Region of Enrollment
United States
2 participants3 participants5 participants
Sex: Female, Male
Female
1 Participants0 Participants1 Participants
Sex: Female, Male
Male
1 Participants3 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 20 / 3
other
Total, other adverse events
0 / 20 / 3
serious
Total, serious adverse events
0 / 20 / 3

Outcome results

Primary

Change in Total Opioid Consumption Between Active and Sham Arms.

The sample size is well below the threshold needed to reliably assess outcomes and perform statistical comparisons. As a result, we have provided the raw data for comparison of opioid consumption between the two groups.

Time frame: Day of surgery to Day 5 (120 hours) post-op

Population: The study was terminated prematurely due to sponsor decision, with no clinical rationale for the termination. This was a feasibility study and the test device was deemed end-of-life by the manufacturer. Only 5 subjects were enrolled out of the 60 anticipated -2 with active devices and 3 with sham devices. All available demographic and outcome measure data from the limited sample size have been reported. Further data reporting would be statistically inappropriate due to the sample size.

ArmMeasureGroupValue (NUMBER)
Bridge DeviceChange in Total Opioid Consumption Between Active and Sham Arms.Oxycodone 5mg1 doses
Bridge DeviceChange in Total Opioid Consumption Between Active and Sham Arms.Tramadol 50mg0 doses
Bridge DeviceChange in Total Opioid Consumption Between Active and Sham Arms.Meloxicam 15mg0 doses
Sham DeviceChange in Total Opioid Consumption Between Active and Sham Arms.Oxycodone 5mg33 doses
Sham DeviceChange in Total Opioid Consumption Between Active and Sham Arms.Tramadol 50mg5 doses
Sham DeviceChange in Total Opioid Consumption Between Active and Sham Arms.Meloxicam 15mg7 doses
Secondary

Change in Functional Recovery Between Active and Sham Arms Assessed Using the 12-Item Short Form Survey (SF-12) Collected on Post-Op Day 30

Subjects will also complete the 12-Item Short Form Survey (SF-12) on Post-Op day 30 to evaluate quality of recovery.

Time frame: Day of surgery to post-operative day 30.

Population: No data was collected for this outcome measure. The study was terminated prematurely due to sponsor decision, with no clinical rationale for the termination. This was a feasibility study and the test device was deemed end-of-life by the manufacturer. Only 5 subjects were enrolled out of the 60 anticipated -2 with active devices and 3 with sham devices. All available demographic and outcome measure data from the limited sample have been reported.

Secondary

Change in Functional Recovery Between Active and Sham Arms Assessed Using the Timed Up and Go (TUG) Assessment Collected on Post-Op Day 30

Functional recovery will be assessed daily from day of surgery to post-op day 5, using the Timed Up and Go assessment to assess mobility.

Time frame: Day of surgery to post-operative day 30.

Population: No data was collected for this outcome measure. The study was terminated prematurely due to sponsor decision, with no clinical rationale for the termination. This was a feasibility study and the test device was deemed end-of-life by the manufacturer. Only 5 subjects were enrolled out of the 60 anticipated -2 with active devices and 3 with sham devices. All available demographic and outcome measure data from the limited sample have been reported.

Secondary

Change in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.

Pain scores using a numerical scale will be collected at rest and movement and will be obtained prior to surgery, in the recovery room, prior to leaving the recovery room, every 6 hours during the first 24 hrs, and at 48, 72, 96 and 120 hours post-operatively. Subjects will use a 0-10 numeric scale (0 indicating no pain and 10 indicating extreme pain).

Time frame: Day of surgery to Day 5 (120 hours) post-op

Population: The study was terminated prematurely due to sponsor decision, with no clinical rationale for the termination. This was a feasibility study and the test device was deemed end-of-life by the manufacturer. Only 5 subjects were enrolled out of the 60 anticipated -2 with active devices and 3 with sham devices. All available demographic and outcome measure data from the limited sample have been reported. Further data reporting would be statistically inappropriate due to the sample size.

ArmMeasureGroupValue (NUMBER)
Bridge DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 2 (48 hours) post-op4 score on a scale
Bridge DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 1 (24 hours) post-op8 score on a scale
Bridge DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 5 (120 hours) post-op4 score on a scale
Bridge DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.18 hours post-op7 score on a scale
Bridge DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 4 (96 hours) post-op3 score on a scale
Bridge DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.6 hours post-op9 score on a scale
Bridge DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 3 (72 hours) post-op4 score on a scale
Bridge DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.12 hours post-op7 score on a scale
Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 4 (96 hours) post-op4 score on a scale
Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 5 (120 hours) post-op1 score on a scale
Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.12 hours post-op1 score on a scale
Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.6 hours post-op1 score on a scale
Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.18 hours post-op2 score on a scale
Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 1 (24 hours) post-op0 score on a scale
Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 2 (48 hours) post-op1 score on a scale
Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 3 (72 hours) post-op1 score on a scale
Subject 3 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.12 hours post-op7 score on a scale
Subject 3 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 1 (24 hours) post-op6 score on a scale
Subject 3 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 4 (96 hours) post-op5 score on a scale
Subject 3 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 3 (72 hours) post-op5 score on a scale
Subject 3 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 2 (48 hours) post-op4 score on a scale
Subject 3 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.18 hours post-op7 score on a scale
Subject 3 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.6 hours post-op7 score on a scale
Subject 3 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 5 (120 hours) post-op3 score on a scale
Subject 4 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.12 hours post-op4 score on a scale
Subject 4 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 1 (24 hours) post-op1 score on a scale
Subject 4 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 4 (96 hours) post-op2 score on a scale
Subject 4 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 2 (48 hours) post-op4 score on a scale
Subject 4 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.6 hours post-op5 score on a scale
Subject 4 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 5 (120 hours) post-op3 score on a scale
Subject 4 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 3 (72 hours) post-op3 score on a scale
Subject 4 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.18 hours post-op2 score on a scale
Subject 5 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 5 (120 hours) post-op3 score on a scale
Subject 5 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.6 hours post-op5 score on a scale
Subject 5 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.12 hours post-op8 score on a scale
Subject 5 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 1 (24 hours) post-op6 score on a scale
Subject 5 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 2 (48 hours) post-op5 score on a scale
Subject 5 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 3 (72 hours) post-op4 score on a scale
Subject 5 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.Day 4 (96 hours) post-op3 score on a scale
Subject 5 - Sham DeviceChange in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.18 hours post-op6 score on a scale
Secondary

Change in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.

Postoperative nausea and vomiting will be evaluated from immediately after surgery through postoperative day 5, using a 0-10 scale (0 indicating no nausea and 10 indicating extreme nausea).

Time frame: Day of surgery to Day 5 (120 hours) post-op

Population: The study was terminated prematurely due to sponsor decision, with no clinical rationale for the termination. This was a feasibility study and the test device was deemed end-of-life by the manufacturer. Only 5 subjects were enrolled out of the 60 anticipated -2 with active devices and 3 with sham devices. All available demographic and outcome measure data from the limited sample have been reported. Further data reporting would be statistically inappropriate due to the sample size.

ArmMeasureGroupValue (NUMBER)
Bridge DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.12 hours post-op0 score on a scale
Bridge DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 4 (96 hours) post-op0 score on a scale
Bridge DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.18 hours post-op0 score on a scale
Bridge DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 2 (48 hours) post-op0 score on a scale
Bridge DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.6 hours post-op0 score on a scale
Bridge DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 5 (120 hours) post-op0 score on a scale
Bridge DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 3 (72 hours) post-op0 score on a scale
Bridge DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 1 (24 hours) post-op0 score on a scale
Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 4 (96 hours) post-op0 score on a scale
Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.6 hours post-op0 score on a scale
Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 2 (48 hours) post-op0 score on a scale
Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.12 hours post-op0 score on a scale
Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 5 (120 hours) post-op0 score on a scale
Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 1 (24 hours) post-op0 score on a scale
Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.18 hours post-op0 score on a scale
Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 3 (72 hours) post-op0 score on a scale
Subject 3 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.6 hours post-op0 score on a scale
Subject 3 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.12 hours post-op0 score on a scale
Subject 3 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.18 hours post-op0 score on a scale
Subject 3 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 1 (24 hours) post-op3 score on a scale
Subject 3 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 2 (48 hours) post-op0 score on a scale
Subject 3 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 3 (72 hours) post-op0 score on a scale
Subject 3 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 4 (96 hours) post-op0 score on a scale
Subject 3 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 5 (120 hours) post-op0 score on a scale
Subject 4 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 2 (48 hours) post-op0 score on a scale
Subject 4 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.18 hours post-op0 score on a scale
Subject 4 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 3 (72 hours) post-op0 score on a scale
Subject 4 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.12 hours post-op0 score on a scale
Subject 4 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 5 (120 hours) post-op0 score on a scale
Subject 4 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 4 (96 hours) post-op0 score on a scale
Subject 4 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.6 hours post-op0 score on a scale
Subject 4 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 1 (24 hours) post-op0 score on a scale
Subject 5 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 1 (24 hours) post-op0 score on a scale
Subject 5 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.18 hours post-op0 score on a scale
Subject 5 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 2 (48 hours) post-op0 score on a scale
Subject 5 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 5 (120 hours) post-op0 score on a scale
Subject 5 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 4 (96 hours) post-op0 score on a scale
Subject 5 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.Day 3 (72 hours) post-op0 score on a scale
Subject 5 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.12 hours post-op0 score on a scale
Subject 5 - Sham DeviceChange in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.6 hours post-op0 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026